Crossref
Characterization of Blood-Based Molecular Profiling in Pancreatic Adenocarcinoma
ONCOLOGY · 2021
DOI: 10.46883/2021.25920931 ↗Kurz gefasst
Fachartikel in der Zeitschrift ONCOLOGY, 2021. Verfasst von Christine Chung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Swedish Medical Center, Englewood, Colorado, United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, Pancreatic DuctalCirculating Tumor DNAFemaleHigh-Throughput Nucleotide SequencingHumansMaleNeoplasm GradingNeoplasm MetastasisNeoplasm StagingPancreatic NeoplasmsPrognosisRetrospective Studies
Stichwörter der Autor:innen
ctDNAmolecular profilingpancreatic adenocarcinoma
Substanzen
Biomarkers, TumorCirculating Tumor DNA
Autor:innen und Institutionen
- Department of Surgery, Swedish Medical Center, Englewood, Colorado, United States.
- Department of Clinical Oncology Research, Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States.
- Graduate Medical Education, HCA HealthCare, Denver, Colorado, United States.
Zitieren
APA
Chung, C., Galvin, R., Achenbach, E., Dziadkowiec, O., & Sen, S. (2021). Characterization of Blood-Based Molecular Profiling in Pancreatic Adenocarcinoma. ONCOLOGY. https://doi.org/10.46883/2021.25920931
Vancouver
Chung C, Galvin R, Achenbach E, Dziadkowiec O, Sen S. Characterization of Blood-Based Molecular Profiling in Pancreatic Adenocarcinoma. ONCOLOGY. 2021. doi:10.46883/2021.25920931
BibTeX
@article{Chung2021,
author = {Chung, Christine and Galvin, Rachael and Achenbach, Ella and Dziadkowiec, Oliwier and Sen, Shiraj},
title = {Characterization of Blood-Based Molecular Profiling in Pancreatic Adenocarcinoma},
journal = {ONCOLOGY},
year = {2021},
doi = {10.46883/2021.25920931}
}
EUVIMED